 SHANGHAI and GAITHERSBURG, MD., May 19 , 2022 PRNewswire -- I-Mab the Company Nasdaq IMAB, a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it will hold a call with investors at 8 a.m. 